Ibalgin (Ibuprofen)

• Ibalgin (ibuprofen) is used to relieve symptoms in several common inflammatory pathways.
• Pain: reduces mild to moderate pain such as headache, dental or musculoskeletal discomfort.
• Fever: lowers elevated body temperature associated with infections or inflammatory conditions.
• Inflammation: alleviates swelling and stiffness in conditions like arthritis or soft‑tissue injury.

• Ibuprofen exerts its effect by non‑selectively inhibiting cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, which blocks the conversion of arachidonic acid to prostaglandins. The reduced prostaglandin synthesis diminishes inflammation, pain signalling, and fever generation at the site of tissue injury or infection.

Adverse reactions may occur with ibuprofen use and are categorized by frequency and severity.

Common Side Effects

• Gastrointestinal discomfort such as nausea or dyspepsia.
• Headache or dizziness.
• Mild skin rash or itching.
• Elevated blood pressure in susceptible individuals.
• Transient increase in serum creatinine.

Serious or Rare Side Effects

• Gastrointestinal bleeding or ulceration.
• Severe allergic reactions including anaphylaxis.
• Hepatotoxicity or elevated liver enzymes.
• Renal impairment or acute kidney injury.
• Cardiovascular events such as myocardial infarction or stroke.
• Blood dyscrasias like thrombocytopenia.

• Before using Ibalgin, consider the following safety measures.
• Assess renal function: avoid use in patients with severe kidney disease.
• Monitor cardiovascular risk: use cautiously in individuals with heart disease.
• Check for gastrointestinal history: avoid in patients with active ulcers or bleeding.
• Avoid concurrent NSAIDs: do not combine with other non‑steroidal anti‑inflammatory drugs.
• Pregnancy and lactation: consult a physician before use during pregnancy or while breastfeeding.
• Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Ibuprofen can interact with several medication classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of bleeding.
• High‑dose aspirin: heightened gastrointestinal toxicity.
• Selective COX‑2 inhibitors: additive renal and cardiovascular risk.
• Certain antihypertensives (e.g., ACE inhibitors, diuretics): may reduce blood‑pressure control.
• Lithium: ibuprofen can raise serum lithium levels.

Moderate Interactions (Monitor Closely)

• Methotrexate: possible increase in toxicity.
• Corticosteroids: enhanced risk of gastrointestinal ulceration.
• SSRIs or SNRIs: modestly increased bleeding tendency.
• Diuretics: potential for reduced renal perfusion.
• Antidiabetic agents: may affect glycemic control.